Bookmark and Share

Last Minute:          For more news, click here.

Remember me? 

Fall of
-0.76 (-0.93%%) SANOFI - [Ticker: SAN.PA]Chart SANOFI  News SANOFI  Download Historical Prices for Metastock SANOFI and Others  Technical Analysis SANOFI  
Last Trade80.53Last Trade Time2017-11-01 - 21:36:00
Variation-0.76 (-0.93%)Open81.79
Volume2,902,429Average Volume (3m)0
YieldBid / Ask71.12 x 1,000 - 71.74 x 44,000
Former Close81.2952 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
SANOFI -  [Ticker: SAN.PA] chart
Change to SANOFI Interactive Technical Analysis Chart

Last 10 Forum Topics about SANOFI:
No topics about SANOFI [SAN.PA] have been found, but a search on the Forum for more topics related to SANOFI is advised.

 News about SANOFI [SAN.PA]:   (ordered by relevance)
Amgen-Sanofi patent case divides makers of antibody drugs The 'Truth Leaks Out': Justices Struggle with the Science, Sanofi ... Amgen-Sanofi patent case divides makers of antibody drugs  Financial Post Stock Watch: Sanofi, Pfizer And The Aftermath Of Acquisitions  Scrip COPD nod could be worth $3.5B for Sanofi, Regeneron's Dupixent  FiercePharma Sanofi SA (SNY) Up 1.18% in Premarket Trading  InvestorsObserver Sanofi launches new long-acting insulin drug in India  Economic Times The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly  Yahoo Finance Sanofi to cut US insulin prices by up to 78% in January 2024  PMLiVE Could This Label Expansion Be a Growth Catalyst for Sanofi Stock?  The Motley Fool Sanofi/Regeneron?s Dupixent approved by EC for atopic dermatitis ...  PMLiVE Sanofi to acquire Provention Bio in deal worth $2.9bn  PMLiVE Sanofi to cut US price of its most-prescribed insulin by 78% With 58% institutional ownership, Sanofi (EPA:SAN) is a favorite amongst the big guns  Simply Wall St Sanofi/Regeneron?s Dupixent shows promise in atopic hand and ...  PMLiVE Sanofi reports positive new data for multiple sclerosis treatment ...  PMLiVE Justices Wrestle With Amgen-Sanofi Patent Fight Over Repatha  Bloomberg Law Sanofi's site modernization spree rolls on with plan to shift 2000 ...  FiercePharma EPO revokes Amgen antibody patent amid ongoing battle with Sanofi  JUVE Patent Provention Bio: Sanofi Acquires Provention Bio With A 273 ...  Seeking Alpha Seagen goes to Pfizer for $43B; Sanofi buys diabetes partner ...  Endpoints News COPD trial data coming soon for Sanofi, Regneron's Dupixent  FiercePharma Bernie Sanders calls out Sanofi, Novo Nordisk for insulin prices  FiercePharma The IIIs have it! Sanofi's fresh approval of bleeding drug Altuviiio ...  FiercePharma Lilly Slashed Its Insulin Prices. Will Sanofi and Novo Nordisk Do the ...  Managed Healthcare Executive Sanofi Could Be on a Roll With a Strong Performance and Its Latest ...  The Motley Fool Sanofi launches its first smart data sensor that records insulin ...  BioWorld Online Sanofi: Phase-3 study on Hemophilia A treatment met primary ... Successful transaction: Adragos Pharma has officially taken over the ...  RealWire In SCOTUS filing, Amgen claps back at Sanofi and Regeneron in ...  FiercePharma Regeneron, Sanofi's Kevzara nabs polymyalgia rheumatica FDA nod  FiercePharma Sanofi invests in successful Geisinger Commonwealth REACH-HEI ...  Geisinger Vaccine patch maker Vaxess names former Sanofi exec as chief ...  Drug Delivery Business News Sanofi Stock: Pharma Tees Up To Rival Pfizer In RSV Vaccine Battle ...  Investor's Business Daily Alumni @ RopesTalk: Conversation with Beibei Sun, Sanofi  Ropes & Gray LLP Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge ...  FierceBiotech Cold Pain Therapy Market (2023 ? 2030)to Observe Strong ...  Digital Journal Sanofi, Regeneron launch new Dupixent asthma TV ad urging ...  FiercePharma Drug developer QurAlis raises $88 mln in Sanofi-backed funding ...  Reuters Sepsis - Pipeline Insight, 2022: Innovations from SciClone, Sanofi ... public companies who own 60% along with institutions invested in Sanofi India Limited (NSE:SANOFI) saw increase in their holdings value last week  Simply Wall St Sanofi (SNY) Dips More Than Broader Markets: What You Should ...  Nasdaq Sanofi India shares clock biggest intraday gain in 7 months on robust bottomline  Moneycontrol Acer Therapeutics' Product Acquired From Sanofi Fails In Menopause Study  Yahoo Finance Sanofi (SNY), Regeneron Dupixent sBLA Accepted for FDA Review  Nasdaq featured highlights Sanofi, SK Telecom, PBF Energy, Arrow Electronics and Novartis  Yahoo Finance Pakistan defers decision on drug price rise as pharma firms struggle Zacks Industry Outlook Highlights J&J, Novo Nordisk, AstraZeneca ...  Nasdaq SGEN Stock Rockets On $43 Billion Takeover; Sanofi Buys Provention  Investor's Business Daily Lilly wants to treat diabetes differently with new campaign  FiercePharma Amgen Reply Brief Addresses Mischaracterizations by Sanofi, U.S. ... Patently Strategic: SCOTUS in Focus - Amgen v. Sanofi and the ... Novo's high-dose Rybelsus win tees up filings?and rivalries  FiercePharma A Look Into Sanofi's Debt - Sanofi (NASDAQ:SNY)  Benzinga What Do Sanofi And Dexcom See In DarioHealth That The Market Is Missing? Eyeing Lilly, Novartis touts broader adjuvant breast cancer win  FiercePharma Sinusitis Market to Witness Growth by 2032, Estimates DelveInsight ...  Digital Journal White House sheds light on biomanufacturing push  FiercePharma Dividend Stocks: These 2 companies announce 3900% dividend to shareholders  Zee Business Targeted Drug Delivery Market Is Estimated To Grow During 2022 ...  Digital Journal Chronic Myeloid Leukemia Market to Exhibit Significant Growth as Leading Companies Such as Novartis, Ascentage Pharma, Terns Pharmaceuticals, Sanofi, and Others are Exploring the Domain | DelveInsight  Yahoo Finance Asthma Market to Observe Impressive Growth by 2032, Evaluates ...  GlobeNewswire First Hawaiian Bank Has $6.66 Million Stock Holdings in Sanofi ...  MarketBeat Herpes Simplex Virus (HSV) Vaccines Market will Offer Increased ...  Digital Journal Adult Vaccines Market Set for More Growth | GlaxoSmithKline, Sanofi Pasteur, Merck, Novartis  openPR Interleukin Inhibitors Market to Witness Huge Growth by 2029 ...  Digital Journal Sanofi?s enzyme replacement therapy available on NHS to Pompe ...  PMLiVE Class 2 Medicines Recall: Aventis Pharma Limited (t/a Sanofi ...  GOV.UK Signed order Sanofi International Biotech Company Ltd.  GOV.UK GSK and Sanofi shares surge after Zantac ruling victory  Financial Times Sanofi Pasteur COVID-19 vaccine authorised by MHRA  GOV.UK Sanofi and Innate Pharma expand cancer therapeutics collaboration  PMLiVE UK at risk of losing healthcare innovation race with European rivals ...  Financial Times Decision on Sanofi Ltd  GOV.UK Sanofi announces change in R&D leadership  Science Business Sanofi and Regeneron face a high-risk test for Dupixent Is Sanofi's Stock Performance Being Led By Robust Fundamentals?  Simply Wall St Sanofi: The arrival of the 'haute couture' supply chain  Supply Chain Digital Sanofi trade union network building constructive relationship with ...  IndustriALL Global Union Sanofi trudges through tough quarter as vaccine sales slip  FiercePharma Exclusive: Sanofi to let go of staff at vaccine plants in India as part of ... Sanofi and Sobi?s once-weekly haemophilia A treatment approved ...  PMLiVE Sanofi/Regeneron?s Dupixent approved by EC for eosinophilic ...  PMLiVE Sanofi CFO says stock price pummelling grossly overdone  Reuters Sanofi forecasts moderate profit growth on Dupixent demand Big Pharma divided? Pfizer, AZ, Lilly and more support Sanofi in ...  FiercePharma Sanofi pulls phase 3 trial of $3.7B drug as competition heats up  FierceBiotech Sanofi offers refunds for Cablivi in novel model for rebates  Pharmaceutical Technology JPM23: Sanofi has reached the 'steady state' Paul Hudson ...  FiercePharma Sanofi/ Regeneron?s Dupixent recommended by CHMP to treat ...  PMLiVE Sanofi started?and lost?$28B bidding war for Horizon. Is the ...  FiercePharma Sanofi and Regeneron?s Dupixent granted EC approval for prurigo ...  PMLiVE Sanofi moves into swanky new Paris headquarters  FiercePharma AstraZeneca, Sanofi tee up 3-way RSV battle in 2023 as FDA ...  FiercePharma Sanofi inks 5-year deal with Thread to adopt more technology into ...  FierceBiotech GSK takes a cue from Sanofi with plans for a new headquarters  FiercePharma Glooko, Sanofi announce partnership to support diabetes patients  Medical Device Network GSK, Sanofi, Takeda sign with Singapore partnership to advance ...  FiercePharma Surprise, Skepticism And Scorn: Reaction To Rumored Haleon ...  HBW Insight Stocks to Watch in Europe: Chipmakers, Sanofi, Zur Rose  Bloomberg
For more news about SANOFI click here:
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2023 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources